Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia.

Yabin CHEN; Hao LI; Peihao WEN; Jiakai ZHANG; Zhihui WANG; Shengli CAO; Wenzhi GUO

Return

Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia.

Author: Yabin CHEN ¹ ; Hao LI ² ; Peihao WEN ¹ ; Jiakai ZHANG ¹ ; Zhihui WANG ¹ ; Shengli CAO ¹ ; Wenzhi GUO ³
Author Information

1. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
2. Henan Organ Transplantation Centre, Zhengzhou 450052, China.
3. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. fccguowz@zzu.edu.cn.
Publication Type:Journal Article
Keywords: Epithelial sodium channel (ENaC); Hypernatremia; Liver transplantation; Na+/Ca 2+ exchanger (NCX)
MeSH: Animals; Reperfusion Injury/drug therapy*; Hypernatremia/complications*; Rats; Liver/metabolism*; Rats, Inbred Lew; Male; Apoptosis; Sodium-Calcium Exchanger/antagonists & inhibitors*; Reactive Oxygen Species/metabolism*; Oxidative Stress; Epithelial Sodium Channel Blockers/pharmacology*; Epithelial Sodium Channels; Cell Line; Liver Transplantation
From: Journal of Zhejiang University. Science. B 2025;26(5):461-476
CountryChina
Language:English
Abstract: Donors with a serum sodium concentration of >155 mmol/L are extended criteria donors for liver transplantation (LT). Elevated serum sodium of donors leads to an increased incidence of hepatic dysfunction in the early postoperative period of LT; however, the exact mechanism has not been reported. We constructed a Lewis rat model of 70% hepatic parenchymal area subjected to ischemia-reperfusion (I/R) with hypernatremia and a BRL-3A cell model of hypoxia-reoxygenation (H/R) with high-sodium (HS) culture medium precondition. To determine the degree of injury, biochemical analysis, histological analysis, and oxidative stress and apoptosis detection were performed. We applied specific inhibitors of the epithelial sodium channel (ENaC) and Na⁺/Ca²⁺ exchanger (NCX) in vivo and in vitro to verify their roles in injury. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) levels and the area of hepatic necrosis were significantly elevated in the HS+I/R group. Increased reactive oxygen species (ROS) production, myeloperoxidase (MPO)‍-positive cells, and aggravated cellular apoptosis were detected in the HS+I/R group. The HS+H/R group of BRL-3A cells showed significantly increased cellular apoptosis and ROS production compared to the H/R group. The application of amiloride (Amil), a specific inhibitor of ENaC, reduced ischemia-reperfusion injury (IRI) aggravated by HS both in vivo and in vitro, as evidenced by decreased serum transaminases, inflammatory cytokines, apoptosis, and oxidative stress. SN-6, a specific inhibitor of NCX, had a similar effect to Amil. In summary, hypernatremia aggravates hepatic IRI, which can be attenuated by pharmacological inhibition of ENaC or NCX.